Effects of a Self-Regulation Based E-MOTE Program Delivered Via an AI-Assisted Robot and Supported by Mobile Platforms for Newly Diagnosed Gynecologic Cancer Patients

간섭 없음: 컨트롤 그룹

정기 진료

실험적: Intervention Group

The intervention group will receive the E-MOTE program, which includes emotional assessments, a self-relaxation training session, and a Q&A session delivered via the Kebbi AI robot during hospitalization. After discharge, participants will continue to receive the program through the LINE Official Account.

다른: E-MOTE group

Participants in the experimental group will receive the E-MOTE program during hospitalization on the day before surgery, postoperative day 1, and postoperative day 2 via the AI robot. The intervention includes an emotional assessment, followed by dialogue modules tailored to the participant's level of emotional distress, emotion-generated empathetic conversations, a self-affirmation relaxation training session, and a Q&A session. After discharge, participants will continue to receive the E-MOTE program through the LINE Official Account.

고통

연구자들은 주요 결과 측정치로서 디스트레스 온도계(DT)를 활용했습니다. 이 척도는 11점 리커트 척도를 사용하며, 0은 전혀 디스트레스가 없음을 나타내고 10은 가장 심각한 디스트레스를 나타냅니다. 점수가 높을수록 더 심각한 디스트레스를 의미합니다. 점수가 4 이상일 경우, 문제 목록(PL)을 사용하여 정서적 디스트레스에 기여하는 요인을 추가로 파악합니다.

Depression

Investigators utilized the Patient Health Questionnaire (PHQ-9) as the primary outcome measure to assess depression. The scale consists of 9 items, each rated on a 4-point Likert scale (0 = not at all, 3 = nearly every day). The total score ranges from 0 to 27, and depression severity can be categorized as mild (5-9), moderate (10-14), moderately severe (15-19), and severe (20 or above).Higher score indicates a more severe depression.

Quality of Life Measurement

Investigator use the partial itmes of European Organisation for Research and Treatment of Cancer (EORTC QLQ-C30) to measure quality of life. These two item is scored on a scale from 1 to 7, with higher scores indicating better quality of life.

Symptom Severity

Investigators utilized the Numerical Rating Scale to assess participants' subjective experiences by measuring the severity of various symptoms over the past week. Each symptom was rated on a scale from 0 to 10 (0 = no symptoms at all, 10 = the worst severity the participant can imagine). Higher score indicate more severity. This items included difficulty urinating, lower limb lymphedema, hot flashes caused by premature menopause, and perineal dryness.

Stress Index

Objective physiological indicators were measured using wearable smart wristbands, and heart rate variability (HRV) was converted into a stress index using a predefined formula.